Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Laboratory of Immunogenetics, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
mBio. 2021 Jun 29;12(3):e0075321. doi: 10.1128/mBio.00753-21. Epub 2021 May 28.
Artemisinin and its semisynthetic derivatives (ART) are fast acting, potent antimalarials; however, their use in malaria treatment is frequently confounded by recrudescences from bloodstream parasites that enter into and later reactivate from a dormant persister state. Here, we provide evidence that the mitochondria of dihydroartemisinin (DHA)-exposed persisters are dramatically altered and enlarged relative to the mitochondria of young, actively replicating ring forms. Restructured mitochondrial-nuclear associations and an altered metabolic state are consistent with stress from reactive oxygen species. New contacts between the mitochondria and nuclei may support communication pathways of mitochondrial retrograde signaling, resulting in transcriptional changes in the nucleus as a survival response. Further characterization of the organelle communication and metabolic dependencies of persisters may suggest strategies to combat recrudescences of malaria after treatment. The major first-line treatment for malaria, especially the deadliest form caused by Plasmodium falciparum, is combination therapy with an artemisinin-based drug (ART) plus a partner drug to assure complete cure. Without an effective partner drug, ART administration alone can fail because of the ability of small populations of blood-stage malaria parasites to enter into a dormant state and survive repeated treatments for a week or more. Understanding the nature of parasites in dormancy (persisters) and their ability to wake and reestablish actively propagating parasitemias (recrudesce) after ART exposure may suggest strategies to improve treatment outcomes and counter the threats posed by parasites that develop resistance to partner drugs. Here, we show that persisters have dramatically altered mitochondria and mitochondrial-nuclear interactions associated with features of metabolic quiescence. Restructured associations between the mitochondria and nuclei may support signaling pathways that enable the ART survival responses of dormancy.
青蒿素及其半合成衍生物(ART)是快速作用、强效的抗疟药;然而,它们在疟疾治疗中的应用经常因血液寄生虫的复发而受到干扰,这些寄生虫进入休眠的持久状态并随后从休眠状态中重新激活。在这里,我们提供的证据表明,与处于年轻、活跃复制的环形成阶段的寄生虫相比,双氢青蒿素(DHA)暴露的持久寄生虫的线粒体发生了显著改变和扩大。重构的线粒体-核关联和改变的代谢状态与活性氧物种的应激一致。线粒体和核之间的新接触可能支持线粒体逆行信号转导的通讯途径,导致核转录变化作为生存反应。对持久寄生虫的细胞器通讯和代谢依赖性的进一步表征可能提示对抗疟疾治疗后复发的策略。 疟疾的主要一线治疗方法,特别是由恶性疟原虫引起的最致命形式,是联合使用基于青蒿素的药物(ART)加一种伴侣药物进行治疗,以确保完全治愈。如果没有有效的伴侣药物,单独使用 ART 治疗可能会失败,因为一小部分血液阶段疟原虫能够进入休眠状态并在重复治疗一周或更长时间后存活下来。了解休眠(持久)寄生虫的性质及其在 ART 暴露后苏醒并重新建立活跃传播的寄生虫血症(复发)的能力,可能提示改善治疗效果的策略,并对抗对伴侣药物产生抗药性的寄生虫构成的威胁。在这里,我们表明,持久寄生虫的线粒体和线粒体-核相互作用发生了显著改变,与代谢静止的特征有关。线粒体和核之间重构的关联可能支持使 ART 休眠存活反应成为可能的信号转导途径。